1. Home
  2. ETON vs ABVE Comparison

ETON vs ABVE Comparison

Compare ETON & ABVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETON
  • ABVE
  • Stock Information
  • Founded
  • ETON 2017
  • ABVE 2019
  • Country
  • ETON United States
  • ABVE Canada
  • Employees
  • ETON N/A
  • ABVE N/A
  • Industry
  • ETON Biotechnology: Pharmaceutical Preparations
  • ABVE Packaged Foods
  • Sector
  • ETON Health Care
  • ABVE Consumer Staples
  • Exchange
  • ETON Nasdaq
  • ABVE Nasdaq
  • Market Cap
  • ETON 199.5M
  • ABVE 21.3M
  • IPO Year
  • ETON 2018
  • ABVE N/A
  • Fundamental
  • Price
  • ETON $8.82
  • ABVE $0.57
  • Analyst Decision
  • ETON Strong Buy
  • ABVE
  • Analyst Count
  • ETON 3
  • ABVE 0
  • Target Price
  • ETON $12.00
  • ABVE N/A
  • AVG Volume (30 Days)
  • ETON 214.1K
  • ABVE 45.2K
  • Earning Date
  • ETON 11-11-2024
  • ABVE 11-15-2024
  • Dividend Yield
  • ETON N/A
  • ABVE N/A
  • EPS Growth
  • ETON N/A
  • ABVE N/A
  • EPS
  • ETON N/A
  • ABVE N/A
  • Revenue
  • ETON $31,381,000.00
  • ABVE $275,376,450.00
  • Revenue This Year
  • ETON $19.61
  • ABVE N/A
  • Revenue Next Year
  • ETON $35.39
  • ABVE N/A
  • P/E Ratio
  • ETON N/A
  • ABVE N/A
  • Revenue Growth
  • ETON 8.14
  • ABVE N/A
  • 52 Week Low
  • ETON $3.03
  • ABVE $0.47
  • 52 Week High
  • ETON $8.66
  • ABVE $9.48
  • Technical
  • Relative Strength Index (RSI)
  • ETON 76.07
  • ABVE N/A
  • Support Level
  • ETON $7.58
  • ABVE N/A
  • Resistance Level
  • ETON $8.66
  • ABVE N/A
  • Average True Range (ATR)
  • ETON 0.42
  • ABVE 0.00
  • MACD
  • ETON -0.07
  • ABVE 0.00
  • Stochastic Oscillator
  • ETON 91.49
  • ABVE 0.00

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

About ABVE Above Food Ingredients Inc. Common Stock

Above Food Ingredients Inc is a differentiated, regenerative ingredient company. Its products are made with real nutritious, flavorful ingredients and delivered with transparency. Its vision is to create a healthier world — one seed, one field, and one bite at a time. With a robust chain of custody of plant proteins, enabled by scaled operations and infrastructure in primary agriculture and processing, and proprietary seed development capabilities that leverage the power of artificial intelligence driven genomics. The company delivers nutritious foods to businesses and consumers with traceability and sustainability. Above Food's consumer products and brands are available in grocers across Canada and the United States.

Share on Social Networks: